Boehringer Ingelheim has received a score of 100 from the Human Rights Campaign’s (HRC) Corporate Equality Index, indicating that it vets suppliers according to its LGBTQ policies (1). Boehringer Ingelheim has not terminated business relationships due to religious or political views. However, Boehringer fired a group of employees in Missouri for not abiding by the company’s self-imposed vaccine mandate for U.S. employees (2). This brought protests (3). The company offered no testing alternative, but it did offer medical and religious exemptions (4). The workers were unionized and fought the mandate alongside the union (5). They even offered to pay for their own testing out of pocket.

Boehringer Ingelheim’s primary charitable goals are “to improve access to healthcare, and to enhance STEM education, with a focus on the underserved” (1)(2). It does not discriminate against faith-based charities.

Boehringer Ingelheim does not protect its employees from viewpoint discrimination (1).

Boehringer Ingelheim has signed open letters supporting the Equality Act and transgender participation in female sports (1)(2). The company also signed an open letter opposing the Florida Parental Rights in Education Act, which prohibits teaching gender identity and sexual orientation in schools to children in K-3rd grade (3). Boehringer developed “U.S. Workplace Gender Transition Guidelines,” including hormone replacement therapy, psychological therapy, and gender-affirming surgical procedures that it developed directly in coordination with the HRC (4)(5). The company has updated protocols to include transgender individuals in their clinical trials as well (6).

Boehringer Ingelheim’s foundation does not donate to ideological groups or partisan causes hostile to freedom of expression (1).

Boehringer Ingelheim has not used its PAC for ideological purposes (1).